Literature DB >> 8870673

Predicted alpha-helix/beta-sheet secondary structures for the zinc-binding motifs of human papillomavirus E7 and E6 proteins by consensus prediction averaging and spectroscopic studies of E7.

C G Ullman1, P I Haris, D A Galloway, V C Emery, S J Perkins.   

Abstract

The E7 and E6 proteins are the main oncoproteins of human papillomavirus types 16 and 18 (HPV-16 and HPV-18), and possess unknown protein structures. E7 interacts with the cellular tumour-suppressor protein pRB and contains a zinc-binding site with two Cys-Xaa2-Cys motifs spaced 29 or 30 residues apart. E6 interacts with another cellular tumour-suppressor protein p53 and contains two zinc-binding sites, each with two Cys-Xaa2-Cys motifs at a similar spacing of 29 or 30 residues. By using the GOR I/III, Chou-Fasman, SAPIENS and PHD methods, the effectiveness of consensus secondary structure predictions on zinc-finger proteins was first tested with sequences for 160 transcription factors and 72 nuclear hormone receptors. These contain Cys2His2 and Cys2Cys2 zinc-binding regions respectively, and possess known atomic structures. Despite the zinc- and DNA-binding properties of these protein folds, the major alpha-helix structures in both zinc-binding regions were correctly identified. Thus validated, the use of these prediction methods with 47 E7 sequences indicated four well-defined alpha-helix (alpha) and beta-sheet (beta) secondary structure elements in the order beta beta alpha beta in the zinc-binding region of E7 at its C-terminus. The prediction was tested by Fourier transform infrared spectroscopy of recombinant HPV-16 E7 in H2O and 2H2O buffers. Quantitative integration showed that E7 contained similar amounts of alpha-helix and beta-sheet structures, in good agreement with the averaged prediction of alpha-helix and beta-sheet structures in E7 and also with previous circular dichroism studies. Protein fold recognition analyses predicted that the structure of the zinc-binding region in E7 was similar to a beta beta alpha beta motif found in the structure of Protein G. This is consistent with the E7 structure predictions, despite the low sequence similarities with E7. This predicted motif is able to position four Cys residues in proximity to a zinc atom. A model for the zinc-binding motif of E7 was constructed by combining the Protein G coordinates with those for the zinc-binding site in transcription factor TFIIS. Similar analyses for the two zinc-binding motifs in E6 showed that they have different alpha/beta secondary structures from that in E7. When compared with 12 other zinc-binding proteins, these results show that E7 and E6 are predicted to possess novel types of zinc-binding structure.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8870673      PMCID: PMC1217759          DOI: 10.1042/bj3190229

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  57 in total

1.  Transforming Proteins of Human Papillomaviruses.

Authors: 
Journal:  Rev Med Virol       Date:  1996-03       Impact factor: 6.989

2.  Structure-function analysis of the human papillomavirus type 16 E7 oncoprotein.

Authors:  W C Phelps; K Münger; C L Yee; J A Barnes; P M Howley
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

3.  Biochemical and biological differences between E7 oncoproteins of the high- and low-risk human papillomavirus types are determined by amino-terminal sequences.

Authors:  K Münger; C L Yee; W C Phelps; J A Pietenpol; H L Moses; P M Howley
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

4.  Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA.

Authors:  B F Luisi; W X Xu; Z Otwinowski; L P Freedman; K R Yamamoto; P B Sigler
Journal:  Nature       Date:  1991-08-08       Impact factor: 49.962

5.  Definition of general topological equivalence in protein structures. A procedure involving comparison of properties and relationships through simulated annealing and dynamic programming.

Authors:  A Sali; T L Blundell
Journal:  J Mol Biol       Date:  1990-03-20       Impact factor: 5.469

6.  Chemical synthesis of human papillomavirus type 16 E7 oncoprotein: autonomous protein domains for induction of cellular DNA synthesis and for trans activation.

Authors:  J A Rawls; R Pusztai; M Green
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

7.  Mutational analysis of human papillomavirus type 16 E7 functions.

Authors:  S Watanabe; T Kanda; H Sato; A Furuno; K Yoshiike
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

8.  Human papillomavirus type 16 E7 protein expressed in Escherichia coli and monkey COS-1 cells: immunofluorescence detection of the nuclear E7 protein.

Authors:  H Sato; S Watanabe; A Furuno; K Yoshiike
Journal:  Virology       Date:  1989-05       Impact factor: 3.616

9.  The limits of protein secondary structure prediction accuracy from multiple sequence alignment.

Authors:  R B Russell; G J Barton
Journal:  J Mol Biol       Date:  1993-12-20       Impact factor: 5.469

10.  A study of the structure of human complement component factor H by Fourier transform infrared spectroscopy and secondary structure averaging methods.

Authors:  S J Perkins; P I Haris; R B Sim; D Chapman
Journal:  Biochemistry       Date:  1988-05-31       Impact factor: 3.162

View more
  13 in total

1.  Human papillomavirus type 16 E7 oncoprotein binds and inactivates growth-inhibitory insulin-like growth factor binding protein 3.

Authors:  B Mannhardt; S A Weinzimer; M Wagner; M Fiedler; P Cohen; P Jansen-Dürr; W Zwerschke
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

2.  Interaction of the bovine papillomavirus E6 protein with the clathrin adaptor complex AP-1.

Authors:  X Tong; W Boll; T Kirchhausen; P M Howley
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

3.  Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein.

Authors:  W Zwerschke; S Mazurek; P Massimi; L Banks; E Eigenbrodt; P Jansen-Dürr
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

4.  New generic primer system targeting mucosal/genital and cutaneous human papillomaviruses leads to the characterization of HPV 115, a novel Beta-papillomavirus species 3.

Authors:  Diego Chouhy; Mario Gorosito; Adriana Sánchez; Esteban C Serra; Adriana Bergero; Ramón Fernandez Bussy; Adriana A Giri
Journal:  Virology       Date:  2009-11-30       Impact factor: 3.616

5.  Identification of a novel human gammapapillomavirus species.

Authors:  Linlin Li; Pennan Barry; Elaine Yeh; Carol Glaser; David Schnurr; Eric Delwart
Journal:  J Gen Virol       Date:  2009-07-01       Impact factor: 3.891

6.  Sequence-specific binding of recombinant Zbed4 to DNA: insights into Zbed4 participation in gene transcription and its association with other proteins.

Authors:  Vladislav V Mokhonov; Veena P Theendakara; Yekaterina E Gribanova; Novruz B Ahmedli; Debora B Farber
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

7.  Characterization of human papillomavirus type 154 and tissue tropism of gammapapillomaviruses.

Authors:  Agustín Enrique Ure; Ola Forslund
Journal:  PLoS One       Date:  2014-02-13       Impact factor: 3.240

8.  Complete genome sequences of three novel human papillomavirus types, 175, 178, and 180.

Authors:  Hanna Johansson; Ola Forslund
Journal:  Genome Announc       Date:  2014-05-22

9.  Characterization of human papillomavirus subtype 72b.

Authors:  Hanna Johansson; Evgenia Kravtchenko; Ola Forslund
Journal:  Genome Announc       Date:  2014-12-18

10.  Mutagenic Potential ofBos taurus Papillomavirus Type 1 E6 Recombinant Protein: First Description.

Authors:  Rodrigo Pinheiro Araldi; Jacqueline Mazzuchelli-de-Souza; Diego Grando Modolo; Edislane Barreiros de Souza; Thatiana Corrêa de Melo; Diva Denelle Spadacci-Morena; Roberta Fiusa Magnelli; Márcio Augusto Caldas Rocha de Carvalho; Paulo Luis de Sá Júnior; Rodrigo Franco de Carvalho; Willy Beçak; Rita de Cassia Stocco
Journal:  Biomed Res Int       Date:  2015-12-09       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.